A share price of Medical Properties Trust Inc [MPW] is currently trading at $5.97, up 4.74%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MPW shares have gain 4.19% over the last week, with a monthly amount glided 24.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medical Properties Trust Inc [NYSE: MPW] stock has seen the most recent analyst activity on March 12, 2025, when Exane BNP Paribas upgraded its rating to a Outperform and also boosted its price target to $9 from $5. Previously, Colliers Securities upgraded its rating to Buy on September 13, 2024, and kept the price target unchanged to $6.50. On July 02, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $4 on the stock. Deutsche Bank upgraded its rating to a Hold but stick to its price target of $5 on April 17, 2024. Colliers Securities downgraded its rating to a Neutral and reduced its price target to $4.25 on April 10, 2024. Exane BNP Paribas upgraded its rating to Outperform for this stock on March 01, 2024, but kept the price target unchanged to $6. In a note dated January 30, 2024, Deutsche Bank initiated an Sell rating and provided a target price of $2 on this stock.
Medical Properties Trust Inc experienced fluctuations in its stock price throughout the past year between $3.51 and $6.55. Currently, Wall Street analysts expect the stock to reach $7.17 within the next 12 months. Medical Properties Trust Inc [NYSE: MPW] shares were valued at $5.97 at the most recent close of the market. An investor can expect a potential return of 20.1% based on the average MPW price forecast.
Analyzing the MPW fundamentals
Trailing Twelve Months sales for Medical Properties Trust Inc [NYSE:MPW] were 995.55M which represents 289.44% growth. Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at -2.23%, and Net Profit Margin reading is -2.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.39 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.86 points at the first support level, and at 5.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.06, and for the 2nd resistance point, it is at 6.15.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 3.60, the price to book ratio is 0.74.
Transactions by insiders
Recent insider trading involved Hanna James Kevin, Senior VP, Controller & CAO, that happened on Mar 05 ’25 when 7411.0 shares were purchased. Senior VP, Controller & CAO, Hanna James Kevin completed a deal on Dec 26 ’24 to sell 11641.0 shares. Meanwhile, SVP of Operations Hooper Rosa Handley sold 3000.0 shares on Dec 23 ’24.
